Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

25.79
+0.31001.22%
Post-market: 25.890.1000+0.39%17:31 EDT
Volume:4.21M
Turnover:110.22M
Market Cap:2.89B
PE:-25.57
High:26.95
Open:26.09
Low:25.70
Close:25.48
Loading ...

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
08 Mar

Analysts’ Top Healthcare Picks: Editas Medicine (EDIT), Viking Therapeutics (VKTX)

TIPRANKS
·
07 Mar

Viking Therapeutics: Promising Obesity Pipeline and Strategic Growth Catalysts Justify Buy Rating

TIPRANKS
·
06 Mar

Why Viking Therapeutics, Inc. (VKTX) Soared on Tuesday

Insider Monkey
·
06 Mar

Novo Nordisk Plunges 21% in 3 Months: Buy, Sell or Hold the Stock?

Zacks
·
05 Mar

Viking Therapeutics to Participate at Upcoming Investor Conferences

PR Newswire
·
05 Mar

Viking Therapeutics (NasdaqCM:VKTX) Reports US$35M Q4 Loss As Stock Falls 12%

Simply Wall St.
·
05 Mar

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
04 Mar

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

Blockhead
·
03 Mar

ABBV Enters Obesity Bandwagon, Inks $2.2B Licensing Deal for Amylin Drug

Zacks
·
03 Mar

Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note

Zacks
·
01 Mar

Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

Insider Monkey
·
01 Mar

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

Insider Monkey
·
27 Feb

Is Viking Therapeutics a Buy Right Now?

Motley Fool
·
26 Feb

Why this newly public biotech could become a force in obesity treatments

Dow Jones
·
26 Feb

Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect

Zacks
·
25 Feb

Viking Therapeutics (VKTX): Among the Oversold Biotech Stocks to Buy Now

Insider Monkey
·
25 Feb

Should You Buy VKTX Stock Amid Renewed M&A Speculations?

Zacks
·
24 Feb

Citi Reaffirms Their Hold Rating on Viking Therapeutics (VKTX)

TIPRANKS
·
24 Feb

Truist Financial Remains a Buy on Viking Therapeutics (VKTX)

TIPRANKS
·
24 Feb